Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges without Dedicated Psychedelic Research Groups
Research, Drug Development & Manufacturing

The University of New South Wales

3 Trials

The University of New South Wales (UNSW Sydney) is one of Australia’s leading research universities, based in Sydney. UNSW’s School of Psychiatry and affiliated research centers participate in clinical and translational studies into psychedelic-assisted therapies, including psilocybin and MDMA for depression, PTSD, and substance use disorders.

Academic Research

0 papers

Published Papers

0

Trial Involvement

3

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
academic
Website
Visit

Sponsored Trials

2
CompletedIII

Effectiveness of ketamine therapy among patients with treatment-resistant depression: a double-blind, randomised, controlled trial

Start Date
Compounds
Ketamine, Placebo
CompletedI

Ketamine Trial for the Treatment of Depression

Start Date
Compounds
Ketamine, Placebo

Collaborated Trials

1
RecruitingIV

Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant Depression (TREK)

Start Date
Compounds
Ketamine, Esketamine